Organovo Inc. (ONVO)
Organovo Statistics
Share Statistics
Organovo has 1.7M shares outstanding. The number of shares has increased by 42.67% in one year.
| Shares Outstanding | 1.7M |
| Shares Change (YoY) | 42.67% |
| Shares Change (QoQ) | 33.44% |
| Owned by Institutions (%) | 13.85% |
| Shares Floating | 1.67M |
| Failed to Deliver (FTD) Shares | 19 |
| FTD / Avg. Volume | < 0.01% |
Short Selling Information
The latest short interest is 78.04K, so 0.51% of the outstanding shares have been sold short.
| Short Interest | 78.04K |
| Short % of Shares Out | 0.51% |
| Short % of Float | 0.52% |
| Short Ratio (days to cover) | 0.32 |
Valuation Ratios
The PE ratio is -7.7 and the forward PE ratio is -0.47. Organovo's PEG ratio is 0.4.
| PE Ratio | -7.7 |
| Forward PE | -0.47 |
| PS Ratio | 1036.98 |
| Forward PS | 14.3 |
| PB Ratio | 31.39 |
| P/FCF Ratio | -7.69 |
| PEG Ratio | 0.4 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Organovo.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.12, with a Debt / Equity ratio of 0.39.
| Current Ratio | 2.12 |
| Quick Ratio | 1.96 |
| Debt / Equity | 0.39 |
| Debt / EBITDA | -0.09 |
| Debt / FCF | -0.09 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $7.79K |
| Profits Per Employee | $-1.05M |
| Employee Count | 14 |
| Asset Turnover | 0.02 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 2K |
| Effective Tax Rate | -0.01% |
Stock Price Statistics
The stock price has increased by -84.44% in the last 52 weeks. The beta is 1.13, so Organovo's price volatility has been higher than the market average.
| Beta | 1.13 |
| 52-Week Price Change | -84.44% |
| 50-Day Moving Average | 3.99 |
| 200-Day Moving Average | 4.75 |
| Relative Strength Index (RSI) | 36.35 |
| Average Volume (20 Days) | 682.68K |
Income Statement
In the last 12 months, Organovo had revenue of 109K and earned -14.67M in profits. Earnings per share was -1.6.
| Revenue | 109K |
| Gross Profit | 109K |
| Operating Income | -15.09M |
| Net Income | -14.67M |
| EBITDA | -14.81M |
| EBIT | -15.09M |
| Earnings Per Share (EPS) | -1.6 |
Balance Sheet
The company has 2.9M in cash and 1.39M in debt, giving a net cash position of 1.51M.
| Cash & Cash Equivalents | 2.9M |
| Total Debt | 1.39M |
| Net Cash | 1.51M |
| Retained Earnings | -339.67M |
| Total Assets | 3.84M |
| Working Capital | -837K |
Cash Flow
In the last 12 months, operating cash flow was -14.65M and capital expenditures -42K, giving a free cash flow of -14.7M.
| Operating Cash Flow | -14.65M |
| Capital Expenditures | -42K |
| Free Cash Flow | -14.7M |
| FCF Per Share | -1.61 |
Margins
Gross margin is 100%, with operating and profit margins of -13840.37% and -13459.63%.
| Gross Margin | 100% |
| Operating Margin | -13840.37% |
| Pretax Margin | -13457.8% |
| Profit Margin | -13459.63% |
| EBITDA Margin | -13583.49% |
| EBIT Margin | -13840.37% |
| FCF Margin | -13481.65% |
Dividends & Yields
ONVO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
Currently there are no analyst rating for ONVO.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Stock Splits
The last stock split was on Mar 21, 2025. It was a backward split with a ratio of 1:12.
| Last Split Date | Mar 21, 2025 |
| Split Type | backward |
| Split Ratio | 1:12 |
Scores
| Altman Z-Score | -137.54 |
| Piotroski F-Score | 3 |